These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 271142)

  • 21. Intensive chemotherapy for acute myelogenous leukemia.
    Gale RP; Foon KA; Cline MJ; Zighelboim J
    Ann Intern Med; 1981 Jun; 94(6):753-7. PubMed ID: 6940466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune response to human keratoacanthoma.
    Flannery GR; Muller HK
    Br J Dermatol; 1979 Dec; 101(6):625-32. PubMed ID: 394758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sera from irradiated rabbits as a source of complement for immune cytolysis assays.
    Walker WS; Mills B; Mohanakumar T
    Transplantation; 1975 Sep; 20(3):260-2. PubMed ID: 1057809
    [No Abstract]   [Full Text] [Related]  

  • 24. [In vitro anti-leukemia activity of cord blood original cytotoxic T lymphocytes].
    Zeng LJ; Tan H
    Ai Zheng; 2005 Apr; 24(4):419-24. PubMed ID: 15820063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Appearance of abnormal catalase antigen and concurrent deletion of normal antigen in leukocytes of myelogenous leukemia.
    Nishimura ET; Hokama Y; Jim R
    Cancer Res; 1972 Nov; 32(11):2353-8. PubMed ID: 4117177
    [No Abstract]   [Full Text] [Related]  

  • 26. Cytotoxic antibody reactive with cultures of lymphoid cells: occurrence in disease and normal human sera.
    Herberman RB; Nam JM
    J Natl Cancer Inst; 1971 Aug; 47(2):489-94. PubMed ID: 5283788
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-Tumor and Immune Enhancing Activities of Rice Bran Gramisterol on Acute Myelogenous Leukemia.
    Somintara S; Leardkamolkarn V; Suttiarporn P; Mahatheeranont S
    PLoS One; 2016; 11(1):e0146869. PubMed ID: 26752299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunoglobulin levels and complement system activity in leukemia].
    Kiersnowska-Rogowska B; Pietruska Z; Hryszko S; Bielawiec M
    Pol Tyg Lek; 1981 Feb; 36(6):213-6. PubMed ID: 6945567
    [No Abstract]   [Full Text] [Related]  

  • 29. Modifying the biological response to acute myeloid leukemia I. BCG, allogeneic leukemic cells and spontaneous cytotoxicity.
    Arends-Merino A; Sjögren AM; Reizenstein P
    Anticancer Res; 1983; 3(4):239-41. PubMed ID: 6576728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-mediated cytotoxicity as a result of immunotherapy in patients with acute myeloid leukaemia.
    Taylor GM; Harris R; Freeman CB
    Br J Cancer; 1976 Feb; 33(2):137-43. PubMed ID: 1063029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monospecific antigranulocyte sera against human neutrophils, eosinophils, basophils, and myeloblasts.
    Mahmoud AA; Kellermeyer RW; Warren KS
    Lancet; 1974 Nov; 2(7890):1163-6. PubMed ID: 4139589
    [No Abstract]   [Full Text] [Related]  

  • 32. Human leukemia cell antigens: serologic characterization with xenoantisera.
    Mohanakumar T; Metzgar RS; Miller DS
    J Natl Cancer Inst; 1974 May; 52(5):1435-44. PubMed ID: 4208711
    [No Abstract]   [Full Text] [Related]  

  • 33. Transient appearance of HLA-DRw-positive leukocytes in peripheral blood after cessation of antileukemia therapy.
    Casper JT; Duquesnoy RJ; Borella L
    Transplant Proc; 1980 Mar; 12(1):130-3. PubMed ID: 6154351
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunologic reactivity of patients with acute leukemia].
    Gerasimova MV; Rozanova LM; Smirnova AI; Krotova TA; Shcherbakova EG
    Vopr Onkol; 1977; 23(4):30-5. PubMed ID: 268078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigens specific for human lymphocytic and myeloid leukemia cells: detection by nonhuman primate antiserums.
    Metzgar RS; Mohanakumar T; Miller DS
    Science; 1972 Dec; 178(4064):986-8. PubMed ID: 4628523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities.
    Le Roy A; Prébet T; Castellano R; Goubard A; Riccardi F; Fauriat C; Granjeaud S; Benyamine A; Castanier C; Orlanducci F; Ben Amara A; Pont F; Fournié JJ; Collette Y; Mege JL; Vey N; Olive D
    Front Immunol; 2018; 9():977. PubMed ID: 29780393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation of autologous peripheral blood progenitor cells procured after high-dose cytarabine-based consolidation chemotherapy for adults with secondary acute myelogenous leukemia in first remission.
    Schiller G; Lee M; Paquette R; Sawyers C; Khoubian F; Territo M
    Leuk Lymphoma; 1999 May; 33(5-6):475-84. PubMed ID: 10342575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular immune reactions in human acute leukemia.
    Herberman RB
    Hamatol Bluttransfus; 1974; 14():107-18. PubMed ID: 4615044
    [No Abstract]   [Full Text] [Related]  

  • 39. Expression of blood group-like antigens on the T lymphocytes of acute leukaemia patients in remission.
    Pullen S; Hersey P
    Clin Exp Immunol; 1980 Feb; 39(2):403-10. PubMed ID: 6966993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum immunoglobulins in acute myelogenous leukemia.
    Alsabti EA
    Neoplasma; 1979; 26(5):611-5. PubMed ID: 293501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.